Cooley advised 5AM Ventures, a venture capital firm focused on building next-generation life sciences companies, on the close of 5AM Ventures VII, a $450 million early-stage venture capital fund, and 5AM Opportunities II, a $300 million later-stage fund, for a total of $750 million in committed capital. Partners Nicole Peppe and Jimmy Matteucci led the Cooley team advising 5AM Ventures.